Abstract
Objective: To assess experts' opinions about the future of, and potential to improve individual and public health through "tobacco harm reduction" (THR), the use of novel nicotine containing products purporting to reduce the health risks from cigarette smoking.
Design: Semi-structured telephone interviews on nine topic areas, with qualitative content analysis of coded transcripts.
Participants: 29 professionals with expertise related to tobacco and interest in THR, including prominent tobacco control advocates (7), pharmaceutical (3) and tobacco industry scientists/officials (5), non-industry scientists (12), and Congressional staff (2).
Results: Respondents agreed that harm reduction is at minimum theoretically plausible, that characteristics of "good" and "bad" THR products can be identified, that government regulation is essential but not likely in the foreseeable future, and that additional scientific data are very much needed. However, there was no consensus on specifics, such as preferred regulatory strategies or examples of ideal THR products. Disagreement was seen not only across but also within respondent categories. Mistrust of key stakeholders—for example, tobacco control advocates distrust of tobacco industry scientists and vice versa—was pervasive, and cited frequently as a barrier to regulation and collaboration.
Conclusions: Continued dialogue and debate are essential as we enter a new and uncertain era of products purporting to reduce tobacco produced harm. Experts have concluded that effective government regulation is crucial to minimising the risks associated with THR and maximising potential benefits.
Full Text
The Full Text of this article is available as a PDF (71.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bates C., Fagerström K., Jarvis M. J., Kunze M., McNeill A., Ramström L. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob Control. 2003 Dec;12(4):360–367. doi: 10.1136/tc.12.4.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foulds J., Ramstrom L., Burke M., Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003 Dec;12(4):349–359. doi: 10.1136/tc.12.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hatsukami Dorothy K., Slade John, Benowitz Neal L., Giovino Gary A., Gritz Ellen R., Leischow Scott, Warner Kenneth E. Reducing tobacco harm: research challenges and issues. Nicotine Tob Res. 2002;4 (Suppl 2):S89–101. doi: 10.1080/1462220021000032852. [DOI] [PubMed] [Google Scholar]
- Kozlowski L. T., Strasser A. A., Giovino G. A., Erickson P. A., Terza J. V. Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tob Control. 2001 Sep;10(3):201–203. doi: 10.1136/tc.10.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kozlowski Lynn T. Harm reduction, public health, and human rights: smokers have a right to be informed of significant harm reduction options. Nicotine Tob Res. 2002;4 (Suppl 2):S55–S60. doi: 10.1080/1462220021000032843. [DOI] [PubMed] [Google Scholar]
- Page J. A. Federal regulation of tobacco products and products that treat tobacco dependence: are the playing fields level? Food Drug Law J. 1998;53 Suppl:11–42. [PubMed] [Google Scholar]
- Pauly J. L., Lee H. J., Hurley E. L., Cummings K. M., Lesses J. D., Streck R. J. Glass fiber contamination of cigarette filters: an additional health risk to the smoker? Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):967–979. [PubMed] [Google Scholar]
- Shiffman Saul, Gitchell Joe G., Warner Kenneth E., Slade John, Henningfield Jack E., Pinney John M. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Nicotine Tob Res. 2002;4 (Suppl 2):S113–S129. doi: 10.1080/1462220021000032717. [DOI] [PubMed] [Google Scholar]
- Warner K. E., Martin E. G. The US tobacco control community's view of the future of tobacco harm reduction. Tob Control. 2003 Dec;12(4):383–390. doi: 10.1136/tc.12.4.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warner Kenneth E. Tobacco harm reduction: promise and perils. Nicotine Tob Res. 2002;4 (Suppl 2):S61–S71. doi: 10.1080/1462220021000032825. [DOI] [PubMed] [Google Scholar]